Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jibrin Muhammad Yelwa has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interface engineering for efficient charge transfer in polyaniline hybrid supercapacitors: a mini review

    by Jibrin Muhammad Yelwa, Haruna Musa

    A very attractive prototypical pseudocapacitive polymer is polyaniline (PANI), which has extremely high theoretical capacitance, can be intrinsically conductive, and is easily synthesized at a relatively low cost. However, the actual device performance is limited by kinetic losses, large interfacial resistance, instability of the doping, pore blocking, and volume fluctuation, which cause large capacity fades. Deliberate interface engineering, such as the hybridization of PANI with carbons, metal oxides, metal sulfides, MXenes, or 3D scaffolds, is a useful approach to alleviate such problems as long as a deliberate design of the interfaces is performed. Here, we concentrate primarily on the interface design as the main design parameter and, categorize the strategies for interface design based on the charge-transfer function, not on the host material. We focus on the PANI–host and PANI–electrolyte interfaces of PANI hybridized with carbon nanostructures, transition-metal oxides and chalcogenides, MXenes, and polymeric/3D scaffolds that have been published in the last 5 years. Each design choice at the interfaces is correlated with measurable charge-transfer metrics, and five types of recent advances are distinguished: chemical anchoring and functional group design, electronic coupling and percolation network architectures, morphology-controlled access to ions, mechanical buffering architectures, and electrolyte–electrode coupling. Practical measures for charge transfer at the interface are also summarized, which offer clear transferable guidelines for future-generation hybrid supercapacitors based on PANI. This mini-review is the first to classify PANI composites based on their function and to provide a quantitative diagnostic, normalization, and scaling framework of interfacial charge transfer.

  • Open Access

    Polymer-Based Microfluidic Devices for Point-of-Care Diagnostics: A Comprehensive Review

    by Jibrin Muhammad Yelwa, Haruna Musa, Magaji Ladan, Dini Sabo, Husaina Garba Anchau, Hauwa Kinjir, Markus Gaya Jocthan, Checkwube Martin Obiano, Alhagie Drammeh

    Background/objectives: Polymer-based microfluidic platforms have emerged as a critical area for the development of point-of-care (POC) diagnostics, driven by the need for rapid, low-cost, and portable testing solutions. This review examines how these systems utilize polymeric substrates to integrate complex laboratory processes into compact, user-friendly devices for healthcare and environmental applications. Methods: This review examines various polymeric substrates, including polydimethylsiloxane, thermoplastics, paper, and hydrogels. It also discusses diverse fabrication approaches ranging from soft lithography, hot embossing, and laser ablation to three-dimensional printing and paper-based patterning besides detection strategies spanning optical and electrochemical sensing, surface plasmon resonance, and smartphone-based readouts. Results: The unique properties of polymers, including optical transparency, biocompatibility, tunable surface chemistry, and cost-effectiveness, support the development of diagnostic assays for infectious diseases, cancer biomarkers, and environmental monitoring. Advances in fabrication and detection strategies have improved device sensitivity, portability, and scalability. However, there remain challenges related to material selection, standardization, reproducibility, and regulatory translation. Conclusions: Despite these challenges, continued advances in novel polymers, sustainable materials, and integrated “sample-to-answer” systems are expected to accelerate the development of polymer microfluidic devices for POC diagnostics. Nevertheless, overcoming regulatory, manufacturing standardization and clinical validation challenges is essential for their widespread clinical adoption. Ultimately, polymer microfluidic devices have the potential to support decentralized diagnostics and personalized medicine while improving healthcare accessibility.

  • Open Access

    Bio-inspired Self-Healing Concrete for Sustainable Structures: A Critical Review

    by Michael Ojobo, Ikechukwu Solomon Utobuiro, Jibrin Muhammad Yelwa, Alhagie Drammeh

    Cracks provide pathways for water, chlorides, sulfates, and carbon dioxide to penetrate reinforced concrete, while conventional crack repairs are often costly, disruptive, and environmentally burdensome. Bio-inspired self-healing concrete incorporates bacteria, enzymes, fungi, or vascular networks to promote autonomous crack sealing and extend service life. This critical review addresses four research questions: (i) how bio-inspired healing compares with autogenous and non-biological engineered healing; (ii) how biological-agent selection, encapsulation and mix design influence trade-offs among healing performance, mechanical properties and cost; (iii) how reliable and comparable laboratory and field evidence is; and (iv) under which conditions self-healing concrete provides environmental and economic benefits. Literature retrieved from Scopus and Web of Science was screened using predefined criteria and critically synthesised, with emphasis on experimental and field evidence. Microbially induced calcium carbonate precipitation (MICP) generally seals cracks 0.3-0.5 mm wide, although laboratory studies report closure of cracks up to 0.8-0.97 mm and reductions in water permeability exceeding 90%. However, healing-agent production can increase embodied carbon by 36% per m³ in one recent assessment. Environmental benefits therefore depend on achieved service-life extension, avoided repairs and targeted application. Reported life-cycle benefits range from approximately 12% to 75%, depending on assessment boundaries and assumptions. Major limitations include non-standardised testing, uncertain long-term bacterial viability and repeated-healing capacity, limited field evidence and regulatory uncertainty. Research priorities include standardised testing, long-term field monitoring, hybrid healing systems, predictive modelling and engineered living materials.

  • Carbon-Based Nanocomposites for Self-healing Materials

    by Jibrin Muhammad Yelwa, Haruna Musa, Opeoluwa O. Fasanya, Alhagie Drammeh, Jibrin Yusuf Yahaya, Jibrin Abdulkadir, Mustapha Mohammed, Ahmad M. Yamani, Bashir M. Aliyu

  • Open Access

    Pharmacological Modulation of the Microbiome in the Prevention and Treatment of Infectious Diseases: Current Evidence and Future Directions

    by Hareg Zewdu Alehegn, Philbert Nzeyimana, Alhagie Drammeh, Rukayya Garba Anchau, Jibrin Abdulkadir, Idris Bello, O.A. Ogabidu, Danna Saleh Danna, Rufa’i Salihu, M.G. Jocthan, et al.

    Human microbiome is a significant point of contact for immunity building and prevents contagious diseases. If the microbiome is disrupted, especially due to broad-spectrum antibiotics, it will make infections more likely to occur with complex disease outcomes like Clostridium difficile colitis. Pharmacological interventions such as probiotics, prebiotics, and microbiome therapy strategies one to two generations ahead and the transplant method, FMT, are all very promising solutions for infection prevention and treatment through their effects on the microbiome. The purpose of this review is to evaluate the present state of knowledge concerning the relationship between the microbiome and infections and to present some of the new pharmacological microbiome modulation strategies. It gives examples where microbiome-targeted therapy has led to a reduction in the infectious risk, a very welcome situation regarding hospitalized/immunocompromised patients, for instance. Nevertheless, though a lot of people are fascinated by the area, problems such as personalized varieties one by one, institutional prejudices, and regulatory unknowns are still the main issues for clinical translating. The use of microbiome-modulating clinical practices is backed up by the research that goes with infectious disease therapies. These fields' growth will necessarily involve collaboration among scientists from different areas and massive error-free clinical trials to confirm the effectiveness and safety of the treatments in different subcategories of patients and infection strains.

  • Metal Oxides for Energy Storage Devices

    by J.M. Yelwa, H. Musa, Joseph Usman, Magaji Ladan, Balarabe El-Yaqoob, Opeoluwa O. Fasanya, Shuaibu Abdullahi, Ibrahim Jimoh, B.M. Aliyu, J.M. Nasir, et al.

    Metal oxide nanocomposites are extremely important materials in the development of energy storage technologies due to their interesting structural and electrochemical features. With properties such as high surface area, porosity, and improved conductivity, these nanocomposites are definitely vital in enhancing the performance of batteries, supercapacitors, and hybrid energy storage devices. Some of the latest developments in this regard have optimized the synthesis process and material composition so as to realize enhanced capacity, improved cycle stability, power density, and energy density for these devices. Specifically, several developments have been oriented toward the synthesis of metal oxide/graphene hybrids and nitrogen-doped graphene composites with exceptional pseudocapacitive performance and improvements in electrochemical performance. Constant research is ongoing to tackle the challenges of synthesis complexity and environmental concerns in order to develop appropriate methods that are sustainable and scalable in nature. It is supposed that further innovation in metal oxide nanocomposites will unfold the future of energy storage, provide efficient, and high-performance solutions that will support the integration of renewable energy sources and modern electronic devices.


  • Carbon-Based Nanocomposites for Chemical Batteries

    by Jibrin Muhammad Yelwa, Bashir M. Aliyu, Alhagie Drammeh, Kalu M. Kalu, Gueny Amirou Fall, Haruna Musa


  • Polymeric Nanoparticles in Biopharmaceutical Development

    by Jibrin Muhammad Yelwa, Haruna Musa, Alhagie Drammeh, Kalu M. Kalu, Philbert Nzeyimana, Hareg Zewdu Alehegn, Fatima B. Tanimu, Husaina G. Anchau